NCT04617314 2026-01-06
A Study of RC108-ADC in Subjects With Advanced Malignant Solid Tumors
RemeGen Co., Ltd.
Phase 1 Completed
Clinical Trials
6 trialsNCT06132828 2025-07-03
Evaluate the Safety, Tolerability, Pharmacokinetics of DR30206 in Patients With Advanced or Metastatic Solid Tumors
Zhejiang Doer Biologics Co., Ltd.
Phase 1 Recruiting
NCT05037149 2024-03-18
Ph. 1, Evaluation of Safety, Tolerability, PK, Anti-tumor Activity of STP707 IV in Subjects With Solid Tumors
Sirnaomics
Phase 1 Active not recruiting
NCT06116240 2023-11-03
A Clinical Trial of TQB2450 Injection Combined With AL2846 Capsules in Patients With Advanced Solid Tumors
Chia Tai Tianqing Pharmaceutical Group Co., Ltd.
Phase 1 Unknown
NCT04673396 2020-12-21
Phase I Clinical Study for Evaluation of Pharmacokinetic, Safety, Tolerance of Norcantharidin Lipid Microsphere for Injection in Patients With Solid Tumor
Beijing Nuokangda Pharmaceutical Technology Co., Ltd.
Phase 1 Unknown
NCT03286296 2019-08-02
LZM009 to Treat Patients With Advanced Solid Tumors
Livzon Pharmaceutical Group Inc.
Phase 1 Completed